Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 310 Squamous Cell Carcinoma of Head and Neck 163 Head and Neck Neoplasms 145 Carcinoma, Non-Small-Cell Lung 97 Colonic Neoplasms 89 Rectal Neoplasms 81 Neoplasm Metastasis 70 Neoplasms 59 Pancreatic Neoplasms 40 Carcinoma, Squamous Cell 38 Lung Neoplasms 35 Esophageal Neoplasms 25 Breast Neoplasms 22 Stomach Neoplasms 20 Recurrence 20 Laryngeal Neoplasms 17 Carcinoma 17 Tongue Neoplasms 16 Mouth Neoplasms 16 Esophageal Squamous Cell Carcinoma 14 Oropharyngeal Neoplasms 13 Salivary Gland Neoplasms 12 Adenocarcinoma Of Esophagus 12 Hypopharyngeal Neoplasms 11 Laryngeal Diseases 10 Adenocarcinoma of Lung 10 Uterine Cervical Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Ovarian Neoplasms 9 Nasopharyngeal Carcinoma 9

Interventions

Chemoradiotherapy 2 Radiation 1 Paclitaxel 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Colony-Stimulating Factors 1 Cetuximab 1 Carboplatin 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Resectable Esophageal Cancer × Cetuximab × Clear all

NCT00827671 2018-03-09

TRACC

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡